Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$67,505,952
+$22,189,954 QoQ
Shares Held
268,264
+28.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#319
of 4,150 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2024CallValue
$29,622,590
CallShares
166,700
PutValue
$710,800
PutShares
4,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $358,862,750 across 12 Drug Manufacturers - General names. ABBV ranks #2 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
239,779 | $86,828,771 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
268,264 | $67,505,952 | |
| 3 | MRK |
Merck & Co., Inc.
|
362,956 | $46,639,846 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
345,805 | $43,689,003 | |
| 5 | AZN |
Astrazeneca PLC
|
186,676 | $35,397,503 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
508,740 | $29,313,598 | |
| 7 | JNJ |
Johnson & Johnson
|
68,010 | $17,272,499 | |
| 8 | PFE |
Pfizer Inc
|
642,123 | $15,462,321 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,505,952 | 268,264 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $45,315,998 | 208,359 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $23,638,889 | 103,457 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $23,078,286 | 99,673 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $28,361,993 | 152,796 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $37,635,658 | 179,628 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $10,202,467 | 57,414 | Shares | Defined | 2025-02-27 | |
| 2024-12-31 | $29,622,590 | 166,700 | Call | Defined | 2025-02-27 | |
| 2024-12-31 | $710,800 | 4,000 | Put | Defined | 2025-02-27 | |
| 2024-09-30 | $49,547,732 | 250,900 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $59,925,503 | 303,451 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $47,977,745 | 279,721 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $11,573,183 | 63,554 | Shares | Defined | 2024-05-13 | |
| 2023-09-30 | $2,915,911 | 19,562 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,684,125 | 12,500 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $2,780,827 | 20,640 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $8,824,815 | 65,500 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $9,737,507 | 61,100 | Put | Defined | 2023-05-15 | |
| 2023-03-31 | $8,207,555 | 51,500 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $25,040,214 | 157,120 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,596,453 | 90,319 | Shares | Defined | 2023-09-21 | |
| 2022-12-31 | $19,490,166 | 120,600 | Put | Defined | 2023-09-21 | |
| 2022-12-31 | $7,272,450 | 45,000 | Call | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||